Key result
RV-PA uncoupling is linked to ~90% higher all-cause mortality in acute heart failure.
Why the study?
The prognostic significance of non-invasive ventricular-arterial coupling surrogates in patients hospitalized with acute heart failure remains largely unknown systematically.
Does non-invasive assessment of ventriculo-arterial uncoupling predict adverse clinical outcomes in patients hospitalized with acute heart failure?
Meta-Analysis (n=36,989)
Yes
Does non-invasive assessment of ventriculo-arterial uncoupling predict adverse clinical outcomes in patients hospitalized with acute heart failure?
Non-invasive bedside assessment of RV-PA and LV-Ao uncoupling provides significant prognostic value for mortality and in-hospital adverse events in patients admitted with acute heart failure.
RV-PA uncoupling may aid risk stratification in acute HF; leaves open whether it is a modifiable therapeutic target.
In acute heart failure (AHF), non-invasive ventricular-arterial coupling (VAC) surrogates, including right ventricular-pulmonary arterial (RV-PA) and left ventricular-arterial (LV-Ao) coupling, have emerged as practical bedside indices, but their prognostic significance remains largely unknown systematically. We performed a systematic review and meta-analysis to evaluate the prognostic significance of non-invasive VAC assessment, in patients hospitalized with AHF. Outcomes included all-cause mortality, HF hospitalization, length of hospital stay, use of therapies, the composite of all-cause mortality and HF hospitalization, and in-hospital adverse cardiovascular events. Adjusted hazard ratios (aHRs) and odds ratios (aORs) were pooled using random-effects. Subgroup-analyses were performed according to follow-up duration and left ventricular ejection fraction. Thirty-six studies comprising 36,989 patients were analysed. Twenty-eight studies evaluated RV-PA coupling, predominantly the TAPSE/PASP ratio, and eight evaluated LV-Ao coupling, mainly using non-invasive Ea/Ees estimates. RV-PA uncoupling was independently associated with increased all-cause mortality (aHR 1.90; 95% CI 1.42–2.56; I²=49%), with consistent associations at 12 months (aHR 2.03; 95% CI 1.44–2.85) and long-term follow-up (aHR 1.67; 95% CI 1.06–2.64). Associations with HF hospitalization, hospital stay, and the composite endpoint were directionally consistent but not statistically significant. LV-Ao uncoupling was associated with increased in-hospital adverse cardiovascular events (aOR 1.70; 95% CI 1.29–2.24). Sensitivity analyses confirmed robustness of these findings. RV-PA uncoupling predicts mortality, whereas LV-Ao uncoupling identifies patients at increased risk of in-hospital adverse cardiovascular events, supporting VAC-risk-stratification in AHF and future evaluation of VAC-guided therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Guz et al. (2026) conducted a meta-analysis in Acute heart failure (AHF) (n=36,989). Right ventricular-pulmonary arterial (RV-PA) uncoupling vs. Preserved RV-PA coupling was evaluated on All-cause mortality (aHR 1.90, 95% CI 1.42-2.56, p=0.0007). Right ventricular-pulmonary arterial uncoupling was independently associated with an increased risk of all-cause mortality (aHR 1.90) in patients hospitalized with acute heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: